Spero Therapeutics, Inc. (SPRO)
1.11
-0.02
(-1.77%)
USD |
NASDAQ |
Oct 23, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Price : 1.11 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.13 | 1.13 | 1.10 | 1.11 | 316553.0 |
| Oct 22, 2026 | 1.16 | 1.17 | 1.13 | 1.13 | 203273.0 |
| Oct 21, 2026 | 1.21 | 1.22 | 1.165 | 1.17 | 265712.0 |
| Oct 20, 2026 | 1.12 | 1.24 | 1.11 | 1.22 | 679284.0 |
| Oct 19, 2026 | 1.09 | 1.13 | 1.09 | 1.12 | 203032.0 |
| Oct 16, 2026 | 1.14 | 1.17 | 1.09 | 1.10 | 361280.0 |
| Oct 15, 2026 | 1.12 | 1.14 | 1.11 | 1.13 | 233830.0 |
| Oct 14, 2026 | 1.15 | 1.17 | 1.11 | 1.12 | 697611.0 |
| Oct 13, 2026 | 1.19 | 1.203 | 1.15 | 1.15 | 272493.0 |
| Oct 12, 2026 | 1.20 | 1.22 | 1.165 | 1.18 | 414257.0 |
| Oct 09, 2026 | 1.14 | 1.21 | 1.13 | 1.20 | 439176.0 |
| Oct 08, 2026 | 1.20 | 1.22 | 1.13 | 1.14 | 719788.0 |
| Oct 07, 2026 | 1.19 | 1.19 | 1.16 | 1.17 | 236670.0 |
| Oct 06, 2026 | 1.21 | 1.236 | 1.18 | 1.19 | 347570.0 |
| Oct 05, 2026 | 1.17 | 1.20 | 1.15 | 1.16 | 942725.0 |
| Oct 02, 2026 | 1.26 | 1.266 | 1.170 | 1.19 | 906916.0 |
| Oct 01, 2026 | 1.22 | 1.31 | 1.195 | 1.26 | 1.039M |
| Sep 30, 2026 | 1.21 | 1.29 | 1.20 | 1.21 | 558213.0 |
| Sep 29, 2026 | 1.20 | 1.22 | 1.17 | 1.20 | 334908.0 |
| Sep 28, 2026 | 1.22 | 1.22 | 1.175 | 1.19 | 393255.0 |
| Sep 25, 2026 | 1.27 | 1.29 | 1.21 | 1.23 | 542771.0 |
| Sep 24, 2026 | 1.25 | 1.29 | 1.24 | 1.25 | 476932.0 |
| Sep 23, 2026 | 1.36 | 1.398 | 1.24 | 1.26 | 1.403M |
| Sep 22, 2026 | 1.30 | 1.44 | 1.28 | 1.36 | 7.764M |
| Sep 21, 2026 | 1.14 | 1.15 | 1.12 | 1.14 | 319103.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.8971 |
| Fortress Biotech, Inc. | 1.93 |
| Kura Oncology, Inc. | 9.61 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
Price Related Metrics
| PE Ratio | 10.17 |
| PS Ratio | 1.491 |
| Price to Book Value | 1.460 |
| Price to Free Cash Flow | 3.272 |
| Earnings Yield | 9.83% |
| Market Cap | 64.54M |
| Operating PE Ratio | 24.84 |
| Normalized PE Ratio | 9.528 |